NO174198C - Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav - Google Patents
Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt deravInfo
- Publication number
- NO174198C NO174198C NO905327A NO905327A NO174198C NO 174198 C NO174198 C NO 174198C NO 905327 A NO905327 A NO 905327A NO 905327 A NO905327 A NO 905327A NO 174198 C NO174198 C NO 174198C
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- trifluorobutylcarbamoyl
- methylphenylsulfonyl
- indol
- benzamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/15—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898927981A GB8927981D0 (en) | 1989-12-11 | 1989-12-11 | Carbamoyl derivative |
Publications (4)
Publication Number | Publication Date |
---|---|
NO905327D0 NO905327D0 (no) | 1990-12-10 |
NO905327L NO905327L (no) | 1991-06-12 |
NO174198B NO174198B (no) | 1993-12-20 |
NO174198C true NO174198C (no) | 1994-04-06 |
Family
ID=10667774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO905327A NO174198C (no) | 1989-12-11 | 1990-12-10 | Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav |
Country Status (32)
Country | Link |
---|---|
EP (1) | EP0432984B1 (sr) |
JP (1) | JPH0822849B2 (sr) |
KR (1) | KR100192999B1 (sr) |
CN (1) | CN1025786C (sr) |
AP (1) | AP192A (sr) |
AT (1) | ATE163641T1 (sr) |
AU (1) | AU642182B2 (sr) |
BG (2) | BG60015B2 (sr) |
CA (1) | CA2031897C (sr) |
CZ (1) | CZ614690A3 (sr) |
DE (1) | DE69032083T2 (sr) |
DK (1) | DK0432984T3 (sr) |
ES (1) | ES2112832T3 (sr) |
FI (1) | FI95029C (sr) |
GB (2) | GB8927981D0 (sr) |
GR (1) | GR3026279T3 (sr) |
HK (1) | HK1003830A1 (sr) |
HR (1) | HRP930326B1 (sr) |
HU (2) | HU210441B (sr) |
IE (1) | IE904448A1 (sr) |
IL (1) | IL96621A (sr) |
MY (1) | MY106363A (sr) |
NO (1) | NO174198C (sr) |
PL (2) | PL166516B1 (sr) |
PT (1) | PT96154B (sr) |
RO (1) | RO108562B1 (sr) |
RU (1) | RU2002740C1 (sr) |
SI (1) | SI9012330A (sr) |
SK (1) | SK278528B6 (sr) |
TW (1) | TW219329B (sr) |
YU (1) | YU48218B (sr) |
ZA (1) | ZA909898B (sr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2063479T3 (es) * | 1990-05-04 | 1995-01-01 | Ciba Geigy Ag | Indoles substituidos. |
GB9020338D0 (en) * | 1990-09-18 | 1990-10-31 | Lilly Industries Ltd | Pharmaceutical compounds |
GB9026427D0 (en) * | 1990-12-05 | 1991-01-23 | Ici Plc | Chemical process |
GB9026425D0 (en) * | 1990-12-05 | 1991-01-23 | Ici Plc | Process |
GB9119001D0 (en) * | 1991-09-05 | 1991-10-23 | Ici Plc | Pharmaceutical agents |
ES2050611B1 (es) * | 1992-10-08 | 1994-12-16 | Ici Plc | Una nueva forma fisica de un derivado de carbamoilindol con propiedades antagonistas de leucotrienos. |
GR1001368B (el) * | 1992-10-08 | 1993-10-29 | Ici Plc | Φαρμακευτικοί φορείς. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4524152A (en) * | 1982-12-30 | 1985-06-18 | Pennwalt Corporation | 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure |
GB8623429D0 (en) * | 1985-10-17 | 1986-11-05 | Ici America Inc | Carboximide derivatives |
IE862737L (en) * | 1985-10-17 | 1987-04-17 | Staehler Theo | Heterocyclic compounds |
MY103259A (en) * | 1987-04-15 | 1993-05-29 | Ici America Inc | Aliphatic carboxamides |
GB8906032D0 (en) * | 1988-04-14 | 1989-04-26 | Ici America Inc | Hetera-aliphatic carboxamides |
GB9026425D0 (en) * | 1990-12-05 | 1991-01-23 | Ici Plc | Process |
-
1989
- 1989-12-11 GB GB898927981A patent/GB8927981D0/en active Pending
-
1990
- 1990-12-10 BG BG093426A patent/BG60015B2/bg unknown
- 1990-12-10 RU SU04831920A patent/RU2002740C1/ru not_active IP Right Cessation
- 1990-12-10 CZ CS906146A patent/CZ614690A3/cs not_active IP Right Cessation
- 1990-12-10 ZA ZA909898A patent/ZA909898B/xx unknown
- 1990-12-10 PL PL90288184A patent/PL166516B1/pl unknown
- 1990-12-10 EP EP90313373A patent/EP0432984B1/en not_active Expired - Lifetime
- 1990-12-10 YU YU233090A patent/YU48218B/sh unknown
- 1990-12-10 HU HU908137A patent/HU210441B/hu not_active IP Right Cessation
- 1990-12-10 ES ES90313373T patent/ES2112832T3/es not_active Expired - Lifetime
- 1990-12-10 DK DK90313373T patent/DK0432984T3/da active
- 1990-12-10 NO NO905327A patent/NO174198C/no unknown
- 1990-12-10 IL IL9662190A patent/IL96621A/en not_active IP Right Cessation
- 1990-12-10 MY MYPI90002157A patent/MY106363A/en unknown
- 1990-12-10 GB GB9026797A patent/GB2238790B/en not_active Revoked
- 1990-12-10 CA CA002031897A patent/CA2031897C/en not_active Expired - Fee Related
- 1990-12-10 AT AT90313373T patent/ATE163641T1/de not_active IP Right Cessation
- 1990-12-10 PL PL90304868A patent/PL167449B1/pl unknown
- 1990-12-10 DE DE69032083T patent/DE69032083T2/de not_active Expired - Lifetime
- 1990-12-10 BG BG095502A patent/BG50606A3/xx unknown
- 1990-12-10 RO RO146517A patent/RO108562B1/ro unknown
- 1990-12-10 AP APAP/P/1990/000230A patent/AP192A/en active
- 1990-12-10 IE IE444890A patent/IE904448A1/en not_active IP Right Cessation
- 1990-12-10 AU AU67917/90A patent/AU642182B2/en not_active Ceased
- 1990-12-10 SK SK6146-90A patent/SK278528B6/sk unknown
- 1990-12-10 SI SI9012330A patent/SI9012330A/sl unknown
- 1990-12-11 JP JP2419290A patent/JPH0822849B2/ja not_active Expired - Lifetime
- 1990-12-11 PT PT96154A patent/PT96154B/pt not_active IP Right Cessation
- 1990-12-11 CN CN90110406A patent/CN1025786C/zh not_active Expired - Lifetime
- 1990-12-11 KR KR1019900020547A patent/KR100192999B1/ko not_active IP Right Cessation
- 1990-12-11 FI FI906084A patent/FI95029C/fi not_active IP Right Cessation
- 1990-12-20 TW TW079110705A patent/TW219329B/zh not_active IP Right Cessation
-
1993
- 1993-03-11 HR HRP-2330/90A patent/HRP930326B1/xx not_active IP Right Cessation
-
1995
- 1995-06-12 HU HU95P/P00183P patent/HU210877A9/hu unknown
-
1998
- 1998-03-05 GR GR980400270T patent/GR3026279T3/el unknown
- 1998-04-02 HK HK98102807A patent/HK1003830A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO901684L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
NO871640L (no) | Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater. | |
NO880182L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater. | |
NO874955L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater. | |
NO903941D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater. | |
NO166281C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater. | |
NO883122L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
PT102145A (pt) | Derivados de piperazina acetamida, processo para a sua preparacao e composicoes farmaceuticas. | |
NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
NO174198C (no) | Analogifremgangsmåte for fremst.av den terapeutisk aktive forbindelse 3-metoksy-4-(1-metyl-5-(2-metyl-4,4,4-trifluorbutylkarbamoyl)indol-3-ylmetyl)-N-(2-metylfenyl-sulfonyl)benzamid, eller et farmasöytisk akseptabelt salt derav | |
NO173503C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner | |
NO900697D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater. | |
NO165104C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater. | |
AU2333888A (en) | A cardioprotective agent and a therapeutic agent for ischemic disease comprising N-containing heterocyclic compounds, and a process for the preparation of the same compounds | |
TR27058A (tr) | 2-azabisiklo (2,2,1) hept-5-ene-2 asetik asid bunun türevleri ve ilgili bilesimleri mezkur bilesimlerin hazirlanmasi usul ve mezkur bilesimlerin n-fosfonometilglisin imali icin kullanilmasi. | |
NO913644D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
NO910372L (no) | Fremgangsmaate for fremstilling av heksahydropyrrolo(2,3-b)indolkarbamater-, urea-, amider og beslektede forbindelser og deres anvendelse som medikamenter. | |
NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
DE2960627D1 (en) | 2-(n-(2'chloro-4'-methyl-thienyl-3')-n-(cyclopropylmethyl)-amino) imidazoline (2), its acid addition salts, pharmaceutical preparations containing them and process for their preparation | |
NO174393C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert | |
NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
IE37288B1 (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
CA2154485A1 (en) | Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders | |
NO882279D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive endo-bicyklo (2,2,1) heptyl-adenosin-derivater. |